Neoprobe Corporation

Type: Company

Name: Neoprobe Corporation

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Navidea Biopharmaceuticals (NAVB) Releases Quarterly Earnings, Beats Expectations By $0.01 EPS

Navidea Biopharmaceuticals (NASDAQ: NAVB) announced its earnings results on Wednesday. The company reported ($0.06) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.07) by $0.01, reports. NAVB has been the subject of a number ... [Published American Banking News - Earnings - May 08 2013]

Entities: Navidea Biopharmaceuticals Inc, Neoprobe Corporation, Piper Jaffray Companies

First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Just Released: "Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation)"

(live-PR.com) - Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. ' Navidea ... [Published Live-PR.com - Apr 17 2013]

Entities: Navidea Biopharmaceuticals Inc, Neoprobe Corporation, Private Equity, Mergers & Acquisitions

Quotes

...offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. " Navidea Biopharmaceuticals Inc. (Formerly Neoprobe Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital"

Just Released: "Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation)" [Published Live-PR.com - Apr 17 2013]